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Background and Purpose:The presence of aortic atherosclerosis is an independent risk
factor for secondary stroke.The present study was designed to have an initial exploration
of the correlation between the load and extent of aortic atheroma (AA) and initial stroke
severity or clinical outcome 3months after stroke. Methods:Cardiac-gated chest tomogra-
phy (CGCT) was used to detect and measure AA in patients with acute ischemic stroke as
shown by our group in prior prospective studies and this is part four sub-exploratory study
of the same cohort. The National Institute of Health Stroke Scale (NIHSS) was used to
assess the initial stroke severity, and the modiﬁed Rankin Scale (mRS) was used to assess
3-month outcome. Results:Thirty-two patients underwent CGCT for evaluation of AA, and
21 were found to have AA. AA was more prevalent in patient with NIHSS >6 (14/17 versus
7/15, p-value 0.03). Applying the multiple logistic regression and propensity score adjust-
ment (using the propensity of having AA given the baseline features as covariates) showed
a non-signiﬁcant trend that AA is three times more likely to be associated with NIHSS >6
(p =0.08, OR 3.08, 95% CI 0.94–13.52).There was no evidence of association of AA with
3-month functional outcome (mRS): 11/14 (78.6%) mRS >1 had AA, and 10/18 (55.5%)
of those with mRS ≤1 had AA (p =0.27). Conclusion: In our current study with limited
sample number and exploratory nature, the presence of AA on CGCT with acute ischemic
stroke patients may be associated with worse neurological deﬁcit at presentation. There
was no evidence of association with 3-month functional outcome using the mRS.
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INTRODUCTION
Atherosclerosis in the ascending or the proximal thoracic aorta is
an independent risk factor for secondary stroke (Acarturk et al.,
1995;Jonesetal.,1995;Cardenas,1996;TheFrenchStudyofAortic
Plaques in Stroke Group, 1996; Cohen et al., 1997a,b; Castellanos
et al., 2001; Amanuallah et al., 2002; Zaidat et al., 2002a) The risk
is related to the shape and characteristics of the aortic plaque and
its thickness as measured in millimeters (mm) (Jones et al., 1995;
The French Study of Aortic Plaques in Stroke Group,1996; Zaidat
etal.,2002a)Theestimatedrelativeriskof futurestrokeinpatients
with more than 4mm aortic atheroma (AA) ranges between 1.6
and 4.3 (Acarturk et al., 1995; Jones et al., 1995; Cardenas, 1996;
The French Study of Aortic Plaques in Stroke Group,1996;Cohen
etal.,1997a;Castellanosetal.,2001;Amanuallahetal.,2002;Zaidat
et al., 2002a) The aim of this study is to provide exploratory data
on whether the initial stroke severity and/or the clinical 3-month
disability outcome can be correlated with the presence or absence
of AA as detected on cardiac-gated chest tomography (CGCT).
†Presented in the 55th Annual American Academy of Neurology Meeting.
We have shown in our prior studies that the newer and faster
multi-slice CT scanners and techniques provide reliable informa-
tion about AA in patients presenting with acute ischemic stroke
when compared to transesophageal echocardiography (TEE) and
as part of the same project we prospectively designed this cur-
rent study to correlate the presence of AA with stroke severity
and 3-month clinical outcome (Costello et al., 1992; Chung et al.,
1996; Fuchs et al., 2000; Flohr et al., 2002; Roos et al., 2002; Zai-
dat et al., 2002b, 2003). CGCT is cardiac cycle gated (to limit the
motion artifact) and ultrafast (only a single breath hold to com-
plete the actual study). CGCT was found to delineate AA features
and detect smaller plaques in higher proportions of patients than
TEE (Costello et al., 1992; Acarturk et al., 1995; Cardenas, 1996;
Chung et al., 1996; Cohen et al., 1997a,b; Castellanos et al., 2001;
Amanuallah et al., 2002; Roos et al., 2002; Zaidat et al., 2002a,b)
thus it was chosen to evaluate for AA.
MATERIALS AND METHODS
Patients with acute ischemic stroke, who were admitted to Uni-
versity Hospital of Cleveland, a tertiary medical center, between
February and November of 2000 were identiﬁed. Of this cohort,
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patientswhounderwentCGCTtoevaluateAAwereselected.Over
theintervalofthestudy,therewerenoconsistentguidelinesforthe
use of CGCT in looking for the etiology of ischemic stroke. The
CGCT procedure was selected for the patients who had techni-
cally inadequate TEE studies,or for those in whom TEE had been
unrevealing. To assess for a selection bias, the study sample was
comparedtotheremainingpatientswithTEEprocedureswhodid
not have CGCT.
SELECTION CRITERIA
(1) Adult 18years or older.
(2) Acute ischemic stroke diagnosed by a stroke neurologist.
(3) Completed CGCT for the purpose of evaluating AA.
EXCLUSION CRITERIA
(1) Stroke patients who did not undergo the CGCT.
(2) Patients who could not complete the CGCT.
(3) Theimagequalitywasnotadequateforreliableinterpretation.
STUDY OUTCOMES
The explanatory variable was the presence or absence of AA on
the CGCT and the response variables were stroke severity at pre-
sentation and 3-month outcome. The initial stroke severity was
assessed using the National Institute of Health Stroke Severity
Scale(NIHSS).TheNIHSSisroutinelyrecordedinischemicstroke
patientsadmittedtoourinstitution.TheNIHSSwasdichotomized
to less or equal to 6 points for mild and moderate to severe stroke.
The second clinical outcome of interest is the 3-month mod-
iﬁed Rankin disability scale (modiﬁed Rankin Scale, mRS). The
mRS ranges between 0 and 6, where 0 represents normal func-
tion without any residual deﬁcit following a stroke and 6 indicates
death. The mRS was dichotomized to 0–1 and 2–6 for good and
bad outcomes,respectively.
STATISTICAL ANALYSIS
The statistical analyses were performed using SPSSV11.0.1 (2001,
SPSS Inc.), JMP V3 (SAS Institute, Cary, NC, USA, 1995), and
Analyse-it (by Analyse-It Software Inc., England, UK, 2002).
DESCRIPTIVE STATISTICS
Demographics,clinical,and imaging baseline data were presented
in a table format, giving the mean with standard deviations
(M ±SD) and median with inter-quartile ranges. For categorical
variables, frequencies, proportions, and percentages were pro-
vided. Student’s two sample t-tests were used to compare the
continuous normally distributed data with unequal variances.
Fisher’sexacttestandchi-squarewereusedtocomparethepropor-
tionsamongthebinaryvariables.Levelofsigniﬁcancewasselected
at the conventional and standard type I error of α≤0.05.
OUTCOME ANALYSIS
Associations between atheroma presence and stroke severity as
estimated by NIHSS, or of atheroma presence and 3-month mRS
were examined using multiple logistic regression to adjust for
otherknownstrokeriskfactors,including:age,sex,race,hyperten-
sion(HTN),diabetes(DM),smoking,andcoronaryarterydisease
(CAD). To allow adjustment for other covariates, several models
were built with up to ﬁve covariates in each model in accordance
with parsimonies rule. Factors known to be associated with stroke
severity at presentation were included to adjust for confounders
or effect modiﬁers. Prior to incorporating these factors into the
model, a univariate analysis was performed to asses the relation
of the baseline variables and AA (independent variable) to initial
Stroke Severity (response variable).
Variables were incorporated in the model if they were deemed
clinically signiﬁcant or had a p-value of <0.5 on the univariate
analysis.We allowed for a large p-value because of the sample size
and the nature of the exploratory analysis. Regression coefﬁcients
wereestimatedusingthemaximumlikelihood.Goodnessofﬁtwas
assessed using the likelihood ratio test with chi-square statistics
betweenthefullandreducedmodels.Co-linearitybetweencovari-
ates were assessed by scatter plots and comparing the regression
models with and without the variable of interest.
Due to the small sample size,there was limited ability to adjust
for other covariates simultaneously using the standard logistic
regression,andpropensityscore(PS)analysiswasusedtoconﬁrm
the ﬁndings. The PS technique was implemented to incorporate
allbaselinevariablesintoonecontinuousscorebasedontheprob-
ability of havingAA. The PS is the probability between 0 and 1 for
a subject to have atheroma present given all his baseline variables,
and is estimated using standard logistic regression. The PS model
was evaluated for its ability to discriminate between subjects who
had atheromas and those who did not, using the area under the
receiver operating characteristic (ROC) curve (C Statistic). After
calculating the probability for every patient, the PS was incorpo-
ratedintheregressionmodelasacontinuouscovariateinaddition
to theAA to adjust for confounders (Joffe and Rosenbaum,1999).
RESULTS
Atotalof 32patientswerefoundtohaveundergoneCGCTforthe
purpose of evaluating stroke etiology.
AORTIC ATHEROMA AND INITIAL STROKE SEVERITY
There were 21 patients with AA on CGCT, 7 with NIHSS ≤6 and
14 with NIHSS >6( p =0.03). The univariate analysis revealed
association of these baseline variables with a p-value of less than
0.5 (a larger p-value was used due to the small sample size) when
analyzed against NIHSS: age, ethnicity, HTN, DM, CAD, hyper-
lipidemia, AA thickness, and smoking (see Table 1). CAD, AA
thickness,largeatheroma>4mm(consistentwiththestandardin
the literature of what is thought to be signiﬁcant atheroma thick-
ness), and atheroma presence were associated with worse initial
stroke on univariate analysis (p-value <0.05). Multiple logistic
regression with NIHSS >6 as the response variable and looking at
theeffectofage,CAD,presenceorabsenceofAA,andPS(weighted
variable of baseline characteristics according to univariate result)
was performed. This multivariate analysis model showed that AA
has a slight trend, but no statistical signiﬁcance, with ischemic
stroke presenting with an initial NIHSS >6( p =0.08, OR 3.08,
95% CI 0.94–13.52), as shown in Table 2.
AORTIC ATHEROMA AND 3-MONTH CLINICAL STROKE OUTCOME
On the univariate analyses correlating AA with 3-month disabil-
ity outcome as measured by mRS; the following variables had
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Table 1 | Univariate analysis of the baseline features and initial stroke severity (n,% ,o rM (±SD).
Variables Total: N =32 NIHSS≤6; N =15 NIHSS>6; N =17 p
Atheroma (mm) 3.1±2.4 4.5±2.3 2.5±2.4 0.03
Any atheroma 21 (65.6%) 7/15 (46.7%) 14/17 (82.4%) 0.03
AA>4mm as per literature 15 (46.9%) 4 (26.7%) 11 (64.7%) 0.04
AA calciﬁcation 18 (56.3%) 6 (0.4%) 12 (70.5%) 0.08
AA protrusion 11 (34.4%) 3 (20%) 8 (64.7%) 0.15
AA ulceration 11 (34.4%) 3 (20%) 8 (64.7%) 0.15
Age, years, M ±SD 66.7±13.9 62±17 .7 71±3.3 0.09
ETHNICITY
White 26 (81%) 11 (73.3%) 15 (88.3%) 0.28
Black 6 (19%) 4 (26.7%) 2 (11.8%)
GENDER
Female 17 (53%) 8 (53.3%) 9 (53%) 0.99
Male 15 (47%) 7 (46.7%) 8 (47%)
Hypertension 20 (62.5%) 7 (46.7%) 13 (76.5%) 0.08
Diabetes 10 (31.3%) 3 (20%) 7 (41.2%) 0.27
Hyperlipidemia 12 (37 .5%) 3 (20%) 9 (53%) 0.08
CAD 10 (31.3%) 1 (6.7%) 9 (53%) 0.01
PVD 8 (25%) 3 (20%) 5 (29.4%) 0.70
Smoking 10 (31.3%) 3 (20%) 7 (42.2%) 0.27
CAD, coronary artery disease; PVD, peripheral vascular disease.
Table 2 | The ﬁnal model withAA and propensity score adjustment (response: NIHSS (>6).
Term Estimate Prob>chi-square Odds ratio Lower 95% Upper 95%
Intercept 1.91 0.59
Age −0.08 0.29 0.01 0.77 1.05
CAD [0–1] 1.59 0.03 23.89 1.41 27 .54
Propensity score [1] 4.81 0.06 14.58 1.63 33.31
CT–AA [0–1] 1.125 0.08 3.08 0.94 13.52
a p-value of less than or equal to 0.5 (low power analysis due
to sample size): age, any AA, HTN, DM, hyperlipidemia, and
CAD (Table 3). Standard logistic regression analysis was per-
formed using those variables to predict 3-month stroke outcome
dichotomized at ≤1 mRS. A multiple logistic regression analysis
model using the functional outcome as response and the effect of
AA presence or absence,CAD,age,and PS was performed. PS was
used as a weighted variable to adjust for all baseline variables that
may be associated with AA. The ﬁnal model including AA, age,
CAD, and PS revealed no association between 3-month mRS and
AA presence (p =0.38,OR 0.77,95% CI 0.4–11.31; see Table 4).
DISCUSSION
The principal goal of this investigation was to explore a potential
association between“AA presence and thickness”and the severity
of the neurological deﬁcit at the onset of ischemic stroke. It has
been difﬁcult to correlate stroke severity with the extent of ather-
osclerotic change in pre-cerebral blood vessels (Timsit et al.,1993;
Mitusch et al., 1997; Ferrari et al., 1999; Geraci and Weinberger,
2000;Paciaronietal.,2000;Senetal.,2000;Weinbergeretal.,2000;
Viguier et al., 2001; Matsumura et al., 2002).
Studies of carotid artery atherosclerosis did not ﬁnd a sim-
ple correlation between stroke severity and degree of stenosis
(Timsit et al., 1993; Mitusch et al., 1997; Ferrari et al., 1999;
Geraci and Weinberger, 2000; Paciaroni et al., 2000; Sen et al.,
2000; Weinberger et al., 2000; Viguier et al., 2001; Matsumura
et al., 2002). One study found a correlation between worsened
stroke severity and certain morphological features of carotid
artery plaque, but not the degree of luminal narrowing (Pacia-
roni et al., 2000). There were higher incidences of death and
majordisablingstrokewith“unstable”plaque,andfeaturesinclud-
ing ulceration, irregularities, and mobile protruding atheromas
(Paciaroni et al., 2000). The possible correlation between AA and
stroke severity has not been described previously. One study had
shown a higher proportion of medium size subcortical strokes in
patients with AA (Matsumura et al., 2002). Other studies have
also shown increased risk of stroke severity when complex AA
features are present (Weinberger et al., 2000; Zaidat et al., 2003).
OurresultsindicatethatAApresenceonCGCTmaybeassociated
with worse initial stroke severity, the effect was less pronounced
after adjusting for baseline covariates by applying a logistic
regression model.
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Table 3 | Univariate analysis of the baseline characteristics and 3-month outcome (n,% ,o rM(±SD).
Variables Total: N =32 mRS≤1; n =18 mRS>1; n =14 p
NIHSS>6 17/32 (53.1%) 5/18 (27 .8%) 12/14 (85.7%) 0.002
Atheroma (mm) 3.1±2.4 3.2±2.5 3.9±2.4 0.4
Any atheroma 21 (65.6%) 10 (55.5%) 11 (78.6%) 0.27
AA>4mm 15 (46.9%) 6 (33.3%) 9 (64.3%) 0.15
AA calciﬁcation 18 (56.3%) 9 (50%) 9 (64.3%) 0.49
AA protrusion 11 (34.4%) 5 (27 .8%) 6 (42.9%) 0.47
AA ulceration 11 (34.4%) 6 (33.3%) 5 (35.7%) 0.68
Age, years (M ±SD) 66.7±13.9 62.5±15.6 72.5±8.6 0.05
ETHNICITY
White 26 (81%) 15 (83.3%) 11 (78.6%) 0.68
Black 6 (19%) 3 (16.7%) 3 (21.4%)
GENDER
Female 17 (53%) 10 (55.5%) 7 (50%) 0.99
Male 15 (47%) 8 (44.4%) 7 (50%)
Hypertension 20 (62.5%) 9 (50%) 11 (78.6%) 0.15
Diabetes 10 (31.3%) 2 (11.1%) 8 (57 .1%) 0.01
Hyperlipidemia 12 (37 .5%) 6 (33.3%) 6 (42.9%) 0.54
CAD 10 (31.3%) 2 (11.1%) 8 (57 .1%) 0.01
PVD 8 (25%) 5 (27 .8%) 3 (21.4%) 0.80
Smoking 10 (31.3%) 5 (27 .8%) 5 (35.7%) 0.71
Table 4 | Logistic regression model with propensity score andAA: response functional outcome (modiﬁed Rankin Scale).
Term Estimate Prob>chi-square Odds ratio Lower 95% Upper 95%
Intercept −1.59 0.62
CT–AA −0.25 0.38 0.77 0.4 11.31
CAD [0–1] 1.28 0.08 12.83 1 22.13
Age 0.032 0.54 7 .38 0.93 11.17
Propensity score 1.47 0.02 18.96 4.39 21.48
To explore the correlation of AA with stroke outcome, we also
looked at the association of AA with clinical outcome at 3-month
afterstroke(mRS),sincethelattermaybareahigherqualityof life
andhealthcareimpactthantheinitialstrokeseverity.Ourﬁndings
showed that the plaque thickness was not associated with worse
outcome at 3 months as was hypothesized, after adjusting for the
baseline covariates using standard logistic regression and the PS
(p =0.38). This may be related to good patient recovery despite
having suffered from severe stroke at presentation.
Our preliminary study is limited by the small sample size.
Adjusting for confounding and interaction was not feasible due
to the limited number of covariates that can be incorporated in
the multivariate model.Applying a PS strengthened the study and
allowed for adjustment for the observed but not the hidden bias.
Inconclusion;thepresenceofAAmaybeassociatedwithworse
clinical severity at presentation. These ﬁndings need to be con-
ﬁrmedwithTEEandspiralCTforstroketypesandstrokeseverity
in larger prospective stroke trials.
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